Codelac Neo Drops for internal use 5 mg / ml, 20 ml
Category
Cough
,
Expectorants
,
Thinning phlegm
Scope of the medicinal product
Respiratory system
Release form
Drops
Manufacturer country
Russia
Package quantity, pcs
one
Codelac Neo Cap.
d / int.
approx.
5mg / ml bottle-drop
20ml No. 1
Name ENG
CODELAC NEO
Clinical and pharmacological group
Antitussive drug
ATX code
Butamirate
Dosage
5mg / ml x 20ml
Structure
5 ml of syrup contains:
Active substance: butamirate citrate (in terms of 100% substance) 100 mg
Excipients: sorbitol (Neosorb 70/70 B, sorbitol syrup) - 8100 mg
glycerol (glycerin) - 5800 mg
ethanol 95% (ethyl alcohol 95%) - 61 mg
sodium saccharinate - 23 mg
benzoic acid - 23 mg
vanillin - 23 mg
sodium hydroxide solution 30% - 10 mg
purified water - up to 20 ml
Indications
Dry cough of any etiology (with colds, flu, whooping cough and other conditions)
suppression of cough in the preoperative and postoperative period, during surgery and bronchoscopy.
INN / Active ingredient
butamirate
Storage conditions and periods
At a temperature not higher than 25 degrees.
Expiration date: 5 years
Contraindications
hypersensitivity to drug components
pregnancy (I trimester)
period of breastfeeding
fructose intolerance (oral drops, syrup)
lactose intolerance, lactase deficiency, glucose-galactose malabsorption (modified-release film-coated tablets)
children up to 2 months of age (drops for oral administration), up to 3 years (syrup), up to 18 years (modified release tablets, film-coated).
Specifications
Category
Cough
,
Expectorants
,
Thinning phlegm
Scope of the medicinal product
Respiratory system
Release form
Drops
Manufacturer country
Russia
Package quantity, pcs
one
Scope of application
Pulmonology
Minimum age from
2 months
Way of introduction
Through the mouth
Vacation conditions
Without recipe
Volume, ml.
20 ml
Brand name
OTCPharm
The amount of the dosage form in the primary package
20 ml
Primary packaging type
Dropper bottle
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Central antitussive agent
Anatomical and therapeutic characteristics
R05DB13 Butamirate
Dosage form
Drops for oral administration
Packaging
Box
The target audience
Adult
Dosage (volume) of the substance in the preparation
5 ml: butamirate citrate 100 mg
Expiration date in days
1825
Package weight, g
70
Mode of application
:
Children from 2 to 12 months - 10 drops, 4 times a day
from 1 year to 3 years - 15 drops, 4 times a day
over 3 years old - 25 drops, 4 times a day.
Before using the drug in children under 2 years of age, consult a doctor.
Oral drops, 5 mg / ml (1 ml contains 22 drops).